BackAngiodynamic Overview
Angiodynamic Inc

Angiodynamic Target Price

Analysts' average 12-month price target for Angiodynamic is $20.

Get informed when a big investor buys or sells

+ Follow

Share Price

$15.86

Average Target Price

$19.5023% upside

2 analysts in the last 4 months

High: $20 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-15H.C. WainwrightYi Chen$1919.8% upsideOpen
2026-07-15Canaccord Genuity$2026.1% upsideOpen
2025-10-03Canaccord Genuity$1813.5% upsideOpen
2025-07-16Canaccord GenuityJohn Young$177.2% upsideOpen
2024-10-04Canaccord GenuityWilliam Plovanic$1224.3% downsideOpen
2024-09-20H.C. WainwrightYi Chen$1411.7% downsideOpen
2024-04-05OppenheimerSteven Lichtman$1224.3% downsideOpen
2023-01-06Raymond James$2238.7% upsideOpen
2022-07-13Raymond James$2770.2% upsideOpen

Angiodynamic (ANGO) FAQ

The latest target price for ANGO is $20. Investors often review this figure alongside Angiodynamic's historical trend and sector peers before judging valuation or financial health.

Angiodynamic trades near $15.86 while the consensus target sits at $20 (23.0% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting ANGO's target price ($20), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Angiodynamic's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.